Role of p38 and early growth response factor 1 in the macrophage response to group B streptococcus

Infection and Immunity

Volumn 77, Issue 6, 2009, Pages 2474-2481

  Kenzel, Sybille ^a   Santos Sierra, Sandra ^a   Deshmukh, Sachin D ^a   Moeller, Inga ^a   Ergin, Bilge ^d   Fitzgerald, Katherine A ^b   Lien, Egil ^b   Akira, Shizuo ^c   Golenbock, Douglas T ^b   Henneke, Philipp ^a,e  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ELK 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MYD88 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STREPTOCOCCUS AGALACTIAE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL CULTURE; CELL LINE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; PERITONEUM MACROPHAGE; PHYSIOLOGY; SECRETION;

ANIMALS; CELL LINE; CELLS, CULTURED; CYTOKINES; EARLY GROWTH RESPONSE PROTEIN 1; ETS-DOMAIN PROTEIN ELK-1; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYELOID DIFFERENTIATION FACTOR 88; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STREPTOCOCCUS AGALACTIAE; TRANSCRIPTION FACTOR AP-1;

EID: 66549087371     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01343-08     Document Type: Article

References (38)

1. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, and D. W. Anderson. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681-13686.
2. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304:1014-1018. (Pubitemid 38638100)
3. Carty, M., R. Goodbody, M. Schroder, J. Stack, P. N. Moynagh, and A. G. Bowie. 2006. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7:1074-1081.
4. Cesari, F., V. Rennekampff, K. Vintersten, L. G. Vuong, J. Seibler, J. Bode, F. F. Wiebel, and A. Nordheim. 2004. Elk-1 knock-out mice engineered by Flp recombinase-mediated cassette exchange. Genesis 38:87-92. (Pubitemid 38327896)
5. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689-10692.
6. Fischer, H., M. Yamamoto, S. Akira, B. Beutler, and C. Svanborg. 2006. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur. J. Immunol. 36: 267-277.
7. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198:1043-1055.
8. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972-978. (Pubitemid 46975746)
9. Glomski, I. J., J. H. Fritz, S. J. Keppler, V. Balloy, M. Chignard, M. Mock, and P. L. Goossens. 2007. Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell. Microbiol. 9:502-513.
10. Hajjar, A. M., R. K. Ernst, J. H. Tsai, C. B. Wilson, and S. I. Miller. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-359.
11. Hazzalin, C. A., and L. C. Mahadevan. 2002. MAPK-Regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3:30-40.
12. Henneke, P., and R. Berner. 2006. Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect. Immun. 74:3085-3095.
13. Henneke, P., S. Morath, U. Uematsu, S. Weichert, Pfitzenmaier., O. Takeuchi, A. Muller, C. Poyart, S. Akira, R. Berner, G. Teti, A. Geyer, T. Hartung, P. Trieu-Cuot, D. L. Kasper, and D. T. Golenbock. 2005. Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J. Immunol. 174: 6449-6455. (Pubitemid 40663839)
14. Henneke, P., O. Takeuchi, R. Malley, E. Lien, R. R. Ingalls, M. W. Freeman, T. Mayadas, V. Nizet, S. Akira, D. L. Kasper, and D. T. Golenbock. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol. 169:3970-3977.
15. Henneke, P., O. Takeuchi, J. A. van Strijp, H.-K. Guttormsen, J. A. Smith, A. B. Schromm, T. A. Espevik, S. Akira, V. Nizet, D. L. Kasper, and D. T. Golenbock. 2001. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J. Immunol. 167:7069-7076. (Pubitemid 33144203)
16. Jefferies, C. A., and L. A. J. O'Neill. 2000. Rac1 regulates interleukin 1-induced nuclear factor kappa B activation in an inhibitory protein kappa Balpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression. J. Biol. Chem. 275:3114-3120. doi:10.1074/ jbc.275.5.3114.
17. Jeyaseelan, S., R. Manzer, S. K. Young, M. Yamamoto, S. Akira, R. J. Mason, and G. S. Worthen. 2005. Toll-IL-1 receptor domain-containing adaptor protein is critical for early lung immune responses against Escherichia coli lipopolysaccharide and viable Escherichia coli. J. Immunol. 175: 7484-7495. (Pubitemid 41713446)
18. Jeyaseelan, S., S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen. 2007. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia. J. Immunol. 178:3153-3160. (Pubitemid 46333197)
19. Kenzel, S., G. Mancuso, R. Malley, G. Teti, D. T. Golenbock, and P. Henneke. 2006. c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis. J. Immunol. 176:3181-3188. (Pubitemid 43306981)
20. Kopp, E., R. Medzhitov, J. Carothers, C. Xiao, I. Douglas, C. A. Janeway, and S. Ghosh. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:2059-2071. (Pubitemid 29407347)
21. Kopp, E. B., and R. Medzhitov. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.
22. Lee, K. S., C. A. Scanga, E. M. Bachelder, Q. Chen, and C. M. Snapper. 2007. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88- dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell. Immunol. 245:103-110.
23. 22a. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(ΔΔCT) method. Methods 25:402-408.
24. Mancuso, G., A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, and G. Teti. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172:6324-6329. (Pubitemid 38621240)
25. Mancuso, G., A. Midiri, C. Beninati, G. Piraino, A. Valenti, G. Nicocia, D. Teti, J. Cook, and G. Teti. 2002. Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J. Immunol. 169:1401-1409. (Pubitemid 34809185)
26. Paoletti, L. C., R. A. Ross, and K. D. Johnson. 1996. Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide. Infect. Immun. 64:1220-1226.
27. Rodewald, A. K., A. B. Onderdonk, H. B. Warren, and D. L. Kasper. 1992. Neonatal mouse model of group B streptococcal infection. J. Infect. Dis. 166:635-639.
28. Sacre, S. M., A. M. Lundberg, E. Andreakos, C. Taylor, M. Feldmann, and B. M. Foxwell. 2007. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J. Immunol. 178:2148-2154. (Pubitemid 46233412)
29. Shi, Y., and M. Gaestel. 2002. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 383:1519-1536.
30. Shin, O. S., R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu. 2008. Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect. Immun. 76:2341-2351. doi:10.1128/IAI.01600-07.
31. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
32. Vallejo, J. G., P. Knuefermann, D. L. Mann, and N. Sivasubramanian. 2000. Group B Streptococcus induces TNF-alpha gene expression and activation of the transcription factors NF-kappa B and activator protein-1 in human cord blood monocytes. J. Immunol. 165:419-425. (Pubitemid 30429535)
33. Wu, W., R. D. Mosteller, and D. Broek. 2004. Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol. Cell. Biol. 24:7359-7369.
34. Xiao, C., J. H. Shim, M. Kluppel, S. S. Zhang, C. Dong, R. A. Flavell, X. Y. Fu, J. L. Wrana, B. L. Hogan, and S. Ghosh. 2003. Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis. Genes Dev. 17:2933-2949. (Pubitemid 37523157)
35. Yamamoto, M., S. Sato, H. Hemmi, H. Sanjo, S. Uematsu, T. Kaisho, K. Hoshino, O. Takeuchi, M. Kobayashi, T. Fujita, K. Takeda, and S. Akira. 2002. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420:324-329. (Pubitemid 35398188)
36. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-{beta} promoter in the Tolllike receptor signaling. J. Immunol. 169:6668-6672. (Pubitemid 36899248)
37. Yang, H., D. W. Young, F. Gusovsky, and J. C. Chow. 2000. Cellular events mediated by lipopolysaccharide-stimulated Toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J. Biol. Chem. 275:20861-20866. doi:10.1074/jbc.M002896200.
38. Yates, R. M., and D. G. Russell. 2005. Phagosome maturation proceeds independently of stimulation of Toll-like receptors 2 and 4. Immunity 23: 409-417.